HomeME • NASDAQ
add
23andMe Holding Co.
$1.49
Makalipas ang Oras ng Trabaho:(0.67%)+0.0100
$1.50
Sarado: Mar 6, 6:41:24 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.51
Sakop ng araw
$1.43 - $1.50
Sakop ng taon
$1.34 - $12.76
Market cap
39.85M USD
Average na Volume
349.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 60.26M | 34.67% |
Gastos sa pagpapatakbo | 65.06M | -22.18% |
Net na kita | -53.04M | 80.92% |
Net profit margin | -88.01 | 85.83% |
Kita sa bawat share | — | — |
EBITDA | -21.80M | 62.70% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 79.35M | -67.27% |
Kabuuang asset | 277.42M | -54.39% |
Kabuuang sagutin | 214.70M | -7.06% |
Kabuuang equity | 62.72M | — |
Natitirang share | 26.83M | — |
Presyo para makapag-book | 0.64 | — |
Return on assets | -21.15% | — |
Return on capital | -42.49% | — |
Cash Flow
Net change in cash
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -53.04M | 80.92% |
Cash mula sa mga operasyon | -44.65M | -270.23% |
Cash mula sa pag-invest | 887.00K | 144.09% |
Cash mula sa financing | -19.00K | -118.10% |
Net change in cash | -43.79M | -213.47% |
Malayang cash flow | -20.18M | -469.10% |
Tungkol
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Itinatag
Abr 2006
Headquarters
Website
Mga Empleyado
571